Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 11, 2024
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugateSandra Bibbò, Emily Capone, Giulio Lovato, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 28, 2019
Targeting Antitumoral Proteins to Breast Cancer by Local Administration of Functional Inclusion BodiesMireia Pesarrodona, Toni Jauset, Zamira V Díaz-Riascos, et al.Genes & Development|April 6, 2023
Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanomaMariano F Zacarías-Fluck, Daniel Massó-Vallés, Fabio Giuntini, et al.Life Science Alliance|March 3, 2021
The Wnt signaling receptor Fzd9 is essential for Myc-driven tumorigenesis in pancreatic isletsMariano F Zacarías-Fluck, Toni Jauset, Sandra Martínez-Martín, et al.Nature Communications|August 19, 2014
Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosisDaniela Annibali, Jonathan R Whitfield, Emilia Favuzzi, et al.Nature Medicine|February 6, 2024
MYC targeting by OMO-103 in solid tumors: a phase 1 trialElena Garralda, Marie-Eve Beaulieu, Víctor Moreno, et al.Cancer Research Communications|March 2, 2023
MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and SeedingDaniel Massó-Vallés, Marie-Eve Beaulieu, Toni Jauset, et al.Science Translational Medicine|March 22, 2019
Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapyMarie-Eve Beaulieu, Toni Jauset, Daniel Massó-Vallés, et al.Cell Reports|November 22, 2025
MYC inhibition by Omomyc causes DNA damage and overcomes PARPi resistance in breast cancerFabio Giuntini, Íñigo González-Larreategui, Andrea Herencia-Ropero, et al.Pageof 3